Published in J Natl Cancer Inst on June 01, 1979
The Zone of Localization of Anti-Mouse-Kidney Serum as Determined by Radioautographs. Science (1949) 8.12
A SIMPLIFIED LYOPHIL APPARATUS. Science (1944) 4.56
Plaque forming cells: methodology and theory. Transplant Rev (1974) 3.92
Immunological dissection of human Ia molecules. J Exp Med (1978) 2.93
Production of free light chains of immunoglobulin by a hematopoietic cell line derived from a patient with multiple myeloma. Proc Soc Exp Biol Med (1967) 2.47
Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res (1993) 2.20
Number of binding sites of rabbit macroglobulin antibody and its subunits. Immunochemistry (1965) 2.16
Multiple common properties of human beta2-microglobulin and the common portion fragment derived from HL-A antigen molecules. Proc Natl Acad Sci U S A (1973) 2.08
Serological Reactions with Simple Substances Containing Two or More Haptenic Groups. Proc Natl Acad Sci U S A (1941) 1.60
IgM and IgG anti-hapten antibody: hemolytic, hemagglutinating and precipitating activity. Proc Soc Exp Biol Med (1965) 1.55
Molecular identification of human Ia antigens coded for by a gene locus closely linked to HLA-DR locus. Immunogenetics (1980) 1.48
Immunoglobulin production in human leukemia cell lines. J Immunol (1966) 1.47
Immunoadsorbents with high capacity. Immunochemistry (1965) 1.39
Isolation of rabbit IgA antihapten antibody and demonstration of skin-sensitizing activity in homologous skin. J Exp Med (1966) 1.37
Immunoglobulin production in synchronized cultures of human hematopoietic cell lines. I. Variation of cellular immunoglobulin level with the generation cycle. J Immunol (1969) 1.36
Characterization of soluble substances in plasma carrying HL-A alloantigenic activity and HL-A common antigenic activity. Transplantation (1973) 1.35
Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am J Physiol (1993) 1.30
Absence of reaction of a xenogenic anti-H-2 serum with mouse embryonal carcinoma cells. Transplantation (1978) 1.29
HL-A antigens from hematopoietic cell lines: molecular size and electrophoretic mobility. J Immunol (1971) 1.28
Change in antibody conformation induced by hapten. Proc Natl Acad Sci U S A (1965) 1.27
Radioiodinated soluble HL-A antigens: HL-A alloantigenic characterization and use in radioimmunoassay. J Immunol Methods (1973) 1.26
Combined effects of chemotherapy and immunity against leukemia L1210 in DBA-2 mice. Cancer Res (1969) 1.26
Isolation and characterization of free gamma chain of immunoglobulin produced by an established cell line of human myeloma cell origin. I. Gamma chain in culture medium. J Immunol (1969) 1.23
Alloantigens of human lymphoid cell lines; 'human Ia-like antigens'. Alloantigenic activity and cell line, organ and tissue distribution as determined by radioimmunoassay. Immunology (1977) 1.23
Partial amino acid sequence of mouse beta2-microglobulin. Biochem Biophys Res Commun (1976) 1.20
The 11,000-dalton component of mouse H-2. Isolation and identification. Transplantation (1974) 1.19
The effects of complete modification of amino groups on the antibody activity of antihapten antibodies. Reversible inactivation with maleic anhydride. Biochemistry (1968) 1.19
Immunoglobulin M antibodies with ten combining sites. Science (1968) 1.18
The component fragments obtained by acid dissociation of papain-solubilized H-2 molecules. J Immunogenet (1976) 1.18
An efficient method for isolation of HL-A antigens from hematopoietic cell lines. J Immunol (1971) 1.18
A mouse plasma substance carrying beta2-microglobulin activity and lacking in H-2 alloantigenic activity. J Immunogenet (1976) 1.17
Specific inhibition of the enzymic decarboxylation of S-adenosylmethionine by methylglyoxal bis(guanylhydrazone) and related substances. Biochem J (1974) 1.15
The basic structure and the antigenic characteristics of HL-A antigens. Transplant Rev (1974) 1.14
Monoclonal antibodies recognizing tumor-associated antigen of human ovarian mucinous cystadenocarcinomas. Cancer Res (1982) 1.12
Absence of a serologically detectable association of murine beta2-microglobulin with the embryonic F9 antigen. Transplantation (1976) 1.11
Immunoglobulin production in cloned sublines of a human lymphocytoid cell line. J Immunol (1969) 1.11
Human Ia-like antigens in non-lymphoid organs. Immunology (1979) 1.10
Monoclonal IgA and IgM in the serum of a single patient (SC). I. Sharing of individually specific determinants between IgA and IgM. J Immunol (1973) 1.10
The sequence around the active-center tyrosyl residue of bovine pancreatic carboxypeptidase A. Proc Natl Acad Sci U S A (1967) 1.10
Evidence for multigenic control of immune response to theta-AKR antigen in mice. Transplant Proc (1973) 1.09
Amino acid sequence of the light chain derived from a rabbit anti-p-azobenzoate antibody of restricted heterogeneity. Biochem Biophys Res Commun (1973) 1.09
Common antigen structures of HL-A antigens. I. Antigenic determinants recognizable by rabbits on papain-solubilized HL-A molecular fragments. Immunology (1973) 1.06
Further studies on Th-B, a cell surface antigenic determinant present on mouse B cells, plasma cells and immature thymocytes. Cell Immunol (1976) 1.05
Human transplantation antigens: isolation and radioimmunoassay. Proc Soc Exp Biol Med (1971) 1.05
Common antigenic structures of HL-A antigens. II. Small fragments derived from papain-solubilized HL-A antigen molecules. Immunology (1974) 1.05
Application of the paired label radioantibody technique to tissue sections and cell smears. J Immunol (1967) 1.04
A surface membrane determinant shared by subpopulations of thymocytes and B lymphocytes. J Immunol (1975) 1.04
Common antigenic structures of HL-A antigens. IV. HL-A common portion fragment isolated from spent culture medium of human lymphoid cell lines. Immunology (1974) 1.03
Antibodies of limited heterogeneity: L chains of a single mobility. Immunochemistry (1970) 1.02
Modification of arginine in the active sites of antibodies. Biochemistry (1968) 1.02
Immune response to alloantigens of thymus studied in mice with plaque assay. J Immunol (1971) 1.02
The expression on mouse lymphoid cells of Th-B, an antigen common to mouse B cells and thymus cells. J Immunol (1975) 1.01
Presence of two different immunoglobulin heavy chains in individual cells of established human hematopoietic cell lines. J Immunol (1968) 1.01
Separation of antibodies into fractions with different binding properties. Immunochemistry (1967) 1.00
Prostaglandin modulation of development of cell-mediated immunity in culture. Nature (1980) 1.00
Daily oral care and risk factors for pneumonia among elderly nursing home patients. JAMA (2001) 1.00
Experimental anti-alveolar basement membrane antibody-mediated pneumonitis. I. The role of increased permeability of the alveolar capillary wall induced by oxygen. J Immunol (1981) 1.00
Receptor-blocking factor present in immune serum resembling auto-anti-idiotype antibody. J Immunol (1976) 1.00
Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance. Int J Cancer (1996) 0.99
Modification of tumor regression by immunologic means. Cancer Res (1969) 0.99
Rabbit antiserum against a non-T, non-B leukemia cell line that carries the Ph1 chromosome (NALM-1): antibody specific to a non-T, non-B acute lymphoblastic leukemia antigen. J Natl Cancer Inst (1978) 0.99
Antibody against neoplastic plasma cells. I. Specific surface antigens on mouse myeloma cells. J Immunol (1971) 0.98
Determination of HL-A zygosity by radioimmunoassay. Transplantation (1972) 0.98
Monoclonal IgA and IgM in the serum of a single patient (SC). 3. Immunofluorescent identification of cells producing IgA and IgM. J Immunol (1973) 0.97
Amino acid composition and physicochemical properties of mouse beta2-microglobulin. Biochem Biophys Res Commun (1975) 0.97
Human cell membrane components bound to beta2-microglobulin in T cell-type cell lines. J Immunol (1978) 0.97
Role of tumor necrosis factor in macrophage activation and tumoricidal activity. Cancer Res (1988) 0.97
Preferential recombination of antibody chains to form effective binding sites. J Exp Med (1965) 0.96
HLA-DR typing by radioimmunoassay. Transplantation (1980) 0.96
Specificity in the combination of Fd fragments with L chains to form hapten-binding sites. J Exp Med (1966) 0.94
Common antigenic structures of HL-A antigens. V. An antigenic determinant characteristic of a 33,000-dalton fragment of HL-A molecules. Transplantation (1974) 0.94
A cell surface antigenic determinant present on mouse plasmacytes and only about half of mouse thymocytes. J Immunol (1974) 0.94
Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon. Cancer Res (1987) 0.93
A cross-reaction between beta2-microglobulin and kappa-light chains. J Immunol (1977) 0.93
Tumor-specific idiotype vaccines. I. Generation and characterization of internal image tumor antigen. J Immunol (1986) 0.92
Anti-hapten antibodies of restricted heterogeneity: studies on binding properties and component chains. J Immunol (1972) 0.91
Unique human glycoprotein, alpha1-microglycoprotein: isolation from the urine of a cancer patient and its characterization. Biochemistry (1978) 0.91
Tumoricidal activation of murine resident peritoneal macrophages by interleukin 2 and tumor necrosis factor alpha. Cancer Res (1992) 0.91
Correlation of surface markers of cells of human lymphatic leukemias with disease type. J Natl Cancer Inst (1977) 0.91
Carcinoembryonic antigen-binding immunoglobulin isolated from normal human serum by affinity chromatography. J Natl Cancer Inst (1979) 0.91
Human cell membrane components dominant in T cell lineage: identification and characterization of human TL-like antigens. J Immunol (1979) 0.90
Genetic control of immune response to theta-AKR alloantigen. J Immunol (1972) 0.90
Antibodies against human leukemia cell lines. J Immunol (1967) 0.90
Preparation of fluorescent antibody reagents monospecific to heavy chains of human immunoglobulin. J Immunol (1968) 0.90
Cell population kinetics of fast- and slow-growing transplantable tumors derived from spontaneous mammary tumors of the DBA/2 Ha-DD mouse. Cancer Res (1978) 0.89
Role of tumor necrosis factor and interleukin 1 in gamma-interferon-promoted activation of mouse tumoricidal macrophages. Cancer Res (1989) 0.89
Localization within the heavy chain sequence of tyrosyl peptides from the combining sites in a rabbit anti-3-azopyridine antibody preparation. Biochem Biophys Res Commun (1972) 0.88
Adriamycin-induced modulation of host defenses in tumor-bearing mice. Cancer Res (1992) 0.88
Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice. Cancer Res (1977) 0.88
A normal component in ribbit IgG with affinity for mouse tissues. Immunology (1968) 0.88
Role of free radicals and neutrophils in canine myocardial reperfusion injury: myocardial salvage by a novel free radical scavenger, 2-octadecylascorbic acid. Cardiovasc Res (1989) 0.88
Detection of oxygen-derived free radical generation in the canine postischemic heart during late phase of reperfusion. Circ Res (1990) 0.88
Effects of anticancer drugs on the immune system in humans. Semin Oncol (1989) 0.88
Radioimmunoassay for myeloma idiotype. J Natl Cancer Inst (1977) 0.88
Recovery of antibody activity from inactive hybrids of H and L chains. J Exp Med (1967) 0.88
Ecto-5'-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int J Cancer (1994) 0.88
Carcinogen-binding antigens in rat liver microsomes. Cancer Res (1966) 0.88
Specific binding activity of isolated light chains of antibodies. Science (1967) 0.87
Synthesis of a lipopolysaccharide designed to conjugate haptens and proteins to erythrocyte for use as target cells in passive hemagglutination and hemolytic assays. J Immunol (1979) 0.87
Basic structure of mouse histocompatibility antigens. Transplant Proc (1975) 0.87